These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 29210294)

  • 1. Current and future therapeutic approaches for osteosarcoma.
    Harrison DJ; Geller DS; Gill JD; Lewis VO; Gorlick R
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):39-50. PubMed ID: 29210294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenic Sarcoma: Systemic Chemotherapy Options for Localized Disease.
    Harrison DJ; Schwartz CL
    Curr Treat Options Oncol; 2017 Apr; 18(4):24. PubMed ID: 28391422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
    Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
    J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteosarcoma and other tumors of bone.
    Mertens WC; Bramwell V
    Curr Opin Oncol; 1995 Jul; 7(4):349-54. PubMed ID: 7578383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative therapy for osteosarcoma.
    Errani C; Longhi A; Rossi G; Rimondi E; Biazzo A; Toscano A; Alì N; Ruggieri P; Alberghini M; Picci P; Bacci G; Mercuri M
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):217-27. PubMed ID: 21342041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the best clinical approach to recurrent/refractory osteosarcoma?
    Meazza C; Bastoni S; Scanagatta P
    Expert Rev Anticancer Ther; 2020 May; 20(5):415-428. PubMed ID: 32379504
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide.
    Kleinerman ES
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):927-38. PubMed ID: 7490249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
    Xu M; Xu S; Yu X
    World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastases.
    Mori K; Ando K; Heymann D
    Expert Rev Anticancer Ther; 2008 Feb; 8(2):151-9. PubMed ID: 18279055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteosarcoma: review of the past, impact on the future. The American experience.
    Jaffe N
    Cancer Treat Res; 2009; 152():239-62. PubMed ID: 20213394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muramyl tripeptide-phosphatidyl ethanolamine encapsulated in liposomes (L-MTP-PE) in the treatment of osteosarcoma.
    Meyers PA; Chou AJ
    Adv Exp Med Biol; 2014; 804():307-21. PubMed ID: 24924182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
    Meyers PA; Schwartz CL; Krailo M; Kleinerman ES; Betcher D; Bernstein ML; Conrad E; Ferguson W; Gebhardt M; Goorin AM; Harris MB; Healey J; Huvos A; Link M; Montebello J; Nadel H; Nieder M; Sato J; Siegal G; Weiner M; Wells R; Wold L; Womer R; Grier H
    J Clin Oncol; 2005 Mar; 23(9):2004-11. PubMed ID: 15774791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
    Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
    Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteosarcoma and other tumors of bone.
    Mertens WC; Bramwell V
    Curr Opin Oncol; 1994 Jul; 6(4):384-90. PubMed ID: 7803539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
    Boye K; Del Prever AB; Eriksson M; Saeter G; Tienghi A; Lindholm P; Fagioli F; Skjeldal S; Ferrari S; Hall KS
    Pediatr Blood Cancer; 2014 May; 61(5):840-5. PubMed ID: 24254749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
    J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Osteosarcoma.
    Belayneh R; Fourman MS; Bhogal S; Weiss KR
    Curr Oncol Rep; 2021 Apr; 23(6):71. PubMed ID: 33880674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
    Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
    Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for osteosarcoma - where does it come from? What is it? Where is it going?
    Yamamoto N; Tsuchiya H
    Expert Opin Pharmacother; 2013 Nov; 14(16):2183-93. PubMed ID: 23919484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.